These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Duchenne muscular dystrophy: an updated review of common available therapies. Salmaninejad A; Valilou SF; Bayat H; Ebadi N; Daraei A; Yousefi M; Nesaei A; Mojarrad M Int J Neurosci; 2018 Sep; 128(9):854-864. PubMed ID: 29351004 [TBL] [Abstract][Full Text] [Related]
18. Duchenne muscular dystrophy trajectory in R-DMDdel52 preclinical rat model identifies COMP as biomarker of fibrosis. Taglietti V; Kefi K; Bronisz-Budzyńska I; Mirciloglu B; Rodrigues M; Cardone N; Coulpier F; Periou B; Gentil C; Goddard M; Authier FJ; Pietri-Rouxel F; Malfatti E; Lafuste P; Tiret L; Relaix F Acta Neuropathol Commun; 2022 Apr; 10(1):60. PubMed ID: 35468843 [TBL] [Abstract][Full Text] [Related]
19. A review on mechanistic insights into structure and function of dystrophin protein in pathophysiology and therapeutic targeting of Duchenne muscular dystrophy. Elasbali AM; Al-Soud WA; Anwar S; Alhassan HH; Adnan M; Hassan MI Int J Biol Macromol; 2024 Apr; 264(Pt 1):130544. PubMed ID: 38428778 [TBL] [Abstract][Full Text] [Related]